Vassar emphasized the center's dedication to diversity in dementia research and the significance of recent pharmaceutical advancements like Lecanamab and Donanemab.
Vassar expressed appreciation for research participants and families' contributions, underlining the ongoing need for therapeutic testing in dementia research.
#alzheimers-research #pharmaceutical-breakthroughs #dementia-education #diversity-in-research #clinical-trials
[
Collection
]
[
|
...
]